Endophilin A1/SH3GL2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-79629
Key Product Details
Species Reactivity
Human, Mouse
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptide directed towards the middle region of human SH3GL2The immunogen for this antibody is SH3GL2. Peptide sequence PRREYQPKPRMSLEFPTGDSTQPNGGLSHTGTPKPSGVQMDQPCCRALYD. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for Endophilin A1/SH3GL2 Antibody
Western Blot: Endophilin A1/SH3GL2 Antibody [NBP1-79629]
Western Blot: Endophilin A1/SH3GL2 Antibody [NBP1-79629] - Titration: 0.2-1 ug/ml, Positive Control: Hela cell lysate.Applications for Endophilin A1/SH3GL2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Endophilin A1/SH3GL2
Long Name
SH3-domain GRB2-like 2
Alternate Names
CNSA2, EEN-B1, Endophilin-1, SH3D2A, SH3GL2, SH3P4
Gene Symbol
SH3GL2
UniProt
Additional Endophilin A1/SH3GL2 Products
Product Documents for Endophilin A1/SH3GL2 Antibody
Product Specific Notices for Endophilin A1/SH3GL2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...